Samsung has launched its Certified Re-Newed (CRN) program in the UK, Germany, and France, offering a practical and ...
Samsung Epis Holdings yesterday shared corporate progress and updates at the 44th JP Morgan Healthcare Conference.
Korea JoongAng Daily on MSN
Samsung Epis targets nine additional biosimilars, drug development expansion in growth strategy
Samsung Epis Holdings, the new holding company for Samsung Bioepis, is pursuing a bold expansion strategy focused on pipeline ...
Having secured investigational new drug application (IND) clearance from the U.S. Food and Drug Administration (FDA), SBE303, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback